Skip to main content
ARYA Atherosclerosis logoLink to ARYA Atherosclerosis
. 2024 Jan-Feb;20(1):1–8. doi: 10.48305/arya.2023.42047.2917

Investigation of flow-mediated vasodilatation (FMD) and comparison with carotid intima-media thickness (CIMT) in children with cyanotic congenital heart disease

Mehdi Ghaderian 1, Alireza Ahmadi 1, Narges Navabfar 2, Mohammad Reza Sabri 1, Bahar Dehghan 1, Chehreh Mahdavi 1
PMCID: PMC11331552  PMID: 39165852

Abstract

BACKGROUND:

There is a high mortality rate in cyanotic patients with congenital heart disease (CHD) due to cardiovascular complications. The cardiovascular prognosis is negatively affected by endothelium dysfunction, increased arterial stiffness, and impaired vascular system. This study aimed to determine carotid intimal mean thickness (CIMT) and flow-mediated dilatation (FMD) in a group of children with cyanotic CHD (CCHD).

METHODS:

FMD and CIMT were evaluated for 45 children with CHKD and 38 patients who did not have CHKD over the period 2021 to 2022, as part of this case-control study. In terms of age and gender, the case group has been compared to controls.

RESULTS:

Men accounted for 61.3% of the participants, with a mean standard deviation age of 7.8 5.39 years. In subjects with CCHD, CIMT increased non-significantly and FMD decreased significantly, but systolic blood pressure was significantly higher in patients than in the healthy group. (P=0.003).

CONCLUSION:

FMD was reduced in children with CCHD, but in controls, systolic blood pressure and CIMT were lower. The risk of developing atherosclerosis in CCHD patients may be increased by an increase in CIMT and systolic blood pressure.

Key Words: Congenital Heart Defects, Flow-Mediated Dilatation, Cyanosis, Carotid Intimal-Media Thickness, Vascular Endothelium

Introduction

Significantly, functional, gross primary irregularities of the heart or the substantial intrathoracic vessels present at birth lead to congenital heart disease (CHD)1,2. The prevalence of CHD worldwide is stated to be almost 0.8% to 1.2% of live births, and its incidence in developing countries located in Asia and Africa is comparatively higher than in most developed countries3. Based on the presence or absence of cyanosis, CHDs are divided into two main categories: Acyanotic CHDD and CCHD. Children with CCHD may present with cardiovascular collapse, congestive heart failure (CHF), cyanosis, cyanotic spells, or combinations of these presentations.

Some patients may have pure versions of certain defects, but most have different combinations. Most combinations have a high chance of poor outcomes2,4.

Flow-mediated dilatation (FMD) of the brachial artery along with measurement of carotid intima-media thickness (CIMT) has been suggested as a surrogate marker for the diagnosis of early atherosclerosis5.

These methods are non-invasive and evaluate endothelial function and structure, respectively6.

Previous studies and researchers have shown the relationship between increased CIMT and cardio-vascular disease risk factors such as hypertension, metabolic syndrome, and dyslipidemia.

Also, it has been reported that FMD correlates with impaired endothelium-dependent relaxation in the coronary arteries7-9. One of the first symptoms of atherosclerosis is endothelial dysfunction, which probably has a significant contribution to the development and clinical manifestation of atherosclerosis symptoms10.

Studies have investigated children with CHD and the occurrence of cardiovascular diseases and their relationship with CIMT and FMD. Therefore, this research aims to investigate FMD in children with CCHD and its relationship with CIMT.

Methods

Participants

In 45 patients with CCHD, this case-control study was carried out. In two medical education clinics at Isfahan University of Medical Sciences, it was obtained by unrandom sampling. (the pediatric clinic of Imam Hossein and Shahid Chamran hospitals) and using the CHD registry in Isfahan11 during 2021-2022. Additionally, thirty-eight healthy subjects were selected from the patient’s relatives who were similar to the illness group in terms of age and gender. The inclusion criteria included children of both sexes, age at the start of the study under 18 years, and consent to participate. The exclusion criteria were pulmonary hypertension, systemic hypertension, and a history of taking diuretics, nitrates, sildenafil, or lipid-lowering drugs.

this investigation was approved by The ethics committee of Isfahan University of Medical Sciences (IR.MUI.MED.REC.1400.102). This study met the standards of ethical conduct of the Declaration of Helsinki for patient welfare. The study was explained to the participating children to the extent of their understanding, and consent was collected. All parent’s subjects in the study signed a written informed consent Before registration.

Checking of information on demographic and anthropometric

In this study, a checklist was prepared by a trained individual to record the name, contact information, age, sex, height, and weight of all patients and controls to calculate their body mass index (BMI).

Determination of Carotid Intima-Media Thickness (CIMT) 

Using the Bmode system(MEDISON echo 7; Samsung, Korea) with a 10 MHz linear transducer, an ultrasound scan of the carotid artery was performed. All measurements were performed by the pediatric cardiologist. At this stage, the bilateral carotid artery was examined and CT was performed at the bifurcation level in the common carotid arteries. The image was concentrated on the peripheral wall of the artery, with CIMT defined as the distance from the leading edge of the first echogenic line to the leading edge of the second echogenic line. In the diastolic phase, the thickness of the intima-media was checked on the longitudinal views of the peripheral wall of bilateral distal common carotid arteries (1-3 cm close to the carotid bifurcation). Considering that CIMT was measured three times, the combined mean of right and left common carotid arteries was analyzed.

Evaluation of Flow-Mediated Dilatation (FMD) 

According to recent guidelines1, flow-mediated dilation was evaluated12. To visualize the best brachial artery, the arm was placed in an extended and motionless position, and scanning was performed from the brachial artery in the longitudinal part 3.5 cm above the anterior fossa.

The skin has been identified as a reference for subsequent measurements. The skin has been designated for reference to subsequent measurements after optimal positioning of the transducer. An average recording of three consecutive measurements was carried out over a continuous cardiac cycle. Any change in brachial artery diameter after 60 seconds of reactive hyperemia compared with the baseline measurement after deflation of a cuff around the forearm that was inflated to 50 mmHg above systolic blood pressure for 5 minutes was recorded as FMD. Before the inflation of the cuff, the response of the vessel diameter to reactive hyperemia was reported as a percentage change compared to its size. Following reactive hyperemia, the percentage change in the internal diameter of the brachial artery was initially reported as flow-induced dilatation.

The amount of change in the internal diameter of the brachial artery after reactive hyperemia was initially reported as flow-induced dilatation.

Statistical analysis

All tests were performed with SPSS statistics version 25.0. Quantitative variables are expressed as mean ± standard deviation and qualitative variables as numbers and percentages. After assessing the normality by the Shapiro Wilk test and QQ plot, the student’s t-test and one-way analysis of variance (ANOVA) assessed differences between independent groups for normally distributed quantitative variables, Mann-Whitney’s U-test and Kruskal Wallis test for variables with non-normal distribution, and the chi-square or Fisher exact test for qualitative variables. All results were considered statistically significant at the level of P < 0.05.

Results

A total of 75 subjects (61.3% male) were under the study (45 children with cyanotic heart disease and 30 control people). The mean age (SD) of the subjects under study was 7.8 (5.39) years, ranging from 1 to 20 years. There was no significant difference between the two studied groups in terms of gender and age (P=0.438). Also, the weight in the control group was higher than in the patient group, but this difference was not significant (P=0.052). However, the difference in height and body mass index was found to be significant (P<0.0001). Most of the patients (40%) were diagnosed with pulmonary atresia. The parameters of the enrolled subjects are summarized in Table 1.

Table 1.

characteristics of participants

Characteristics Case (n=45) Control (n=38) P-value
Gender N (%)
Male 31 (70.5) 20 (54.1) 0.167*
Female 13 (29.5) 17 (45.9)
Age [Year]. Mean±SD 4.45 ± 2.54 5.88 ± 4.43 0.438^
Weight [Kg]. Mean±SD 17.28 ± 10.14 25.28 ± 17.02 0.052^
Height [Cm]. Mean±SD 86.75 ± 21.47 112.42 ± 28.35 <0.0001$
BMI 1 Mean±SD 22.45 ± 2.2 17.81 ± 3.6 <0.0001^
Diagnosis N (%)
Tetralogy of Fallot. 27 (60) - -
Pulmonary atresia 18 (40) - -

1Body mass index *chi square test ^ Mann-Whitney's U-test $ Student's t-test

Table 2 compares the CIMT of both groups. The mean CIMT for patients with cyanotic heart disease in the case group was higher than the control group, but it was not statistically significant (P=0.074).

Table 2.

Clinical characteristics of participants

Clinical characteristics Case (n=45) Control (n=38) P-value
Mean±SD
CIMT (mm) 0.38±0.08 0.35±0.1 0.074^
FMD 2 0.065±0.018 0.069±0.019 0.335$
Systolic blood pressure 105.95±12.86 98.81±9.33 0.003^
Diastolic blood presure 62.68±12.09 64.47±9.06 0.535^

^ Mann-Whitney's U-test $ Student's t-test

When comparing diastolic and systolic blood pressure in the two groups, the results showed that in the patient group, systolic blood pressure was significantly higher than in the control group (P=0.003). However, there was no significant difference in diastolic blood pressure between the two groups (P=0.535) (Table 2).

The patients were classified into two groups: those with tetralogy of Fallot and those with pulmonary atresia after repair surgery. When comparing these three groups (pulmonary atresia, tetralogy of Fallot, and control), a significant difference in CIMT was found (P=0.035). In particular, the CIMT in patients with pulmonary atresia was very high compared to a control group. (P=0.008) (Table 3).

Table 3.

Comparison of CIMT and FMD between three groups

Characteristics Group Mean±SD P-value
CIMT (mm) Tetralogy of Fallot. (N=27) 0.37±0.9 0.035*
Pulmonary atresia (N=18) 0.42±0.7
Control (N=38) 0.35±0.1
Tetralogy of Fallot. (N=27) 0.37±0.9 0.074^
Pulmonary atresia (N=18) 0.42±0.7
Pulmonary atresia (N=18) 0.42±0.7 0.008^
Control (N=38) 0.35±0.1
Tetralogy of Fallot (N=27) 0.37±0.9 0.367^
Control (N=38) 0.35±0.1
FMD Tetralogy of Fallot. (N=27) 0.064±0.01 0.606&
Pulmonary atresia (N=18) 0.066±0.01
Control (N=38) 0.069±0.02
Tetralogy of Fallot. (N=27) 0.064±0.01 0.958$
Pulmonary atresia (N=18) 0.066±0.01
Pulmonary atresia (N=18) 0.066±0.01 0.902$
Control (N=38) 0.069±0.02
Tetralogy of Fallot (N=27) 0.064±0.01 0.580$
Control (N=38) 0.069±0.02

^ Mann-Whitney's U-test $ Student's t-test & ANOVA $ Kruskal Wallis test

Also, the mean FMD in the two groups was not significantly different (P=0.335). Similarly, the comparison of FMD between the three groups (pulmonary atresia, tetralogy of Fallot, and control) was not significant y(P=0.606) (Table 3).

Discussion

The present study has shown that in children with CCHD, which is considered a gold standard for evaluating endothelial function, FMD, in conduit arteries, has decreased significantly13. Previous studies using different techniques have investigated endothelial function in CHD patients in different age groups14-16.

The physiology of the brachial artery has been used to investigate endothelium function, including a pediatric cohort where FMD was shown to be significantly decreased in the cyanotic group and is supported by our studies on the reduction of FMD.

However, it was not in line with statistical analysis15. The average FMD was equal to the normal group in the two adult studies and showed no changes17,18, and Other studies showed that FMD was significantly more common in the migraine, syncope, and syncope and migraine groups than control group19.

Age and disease processes may be associated with differences in FMD measures observed between the current study and adult investigations, requiring further studies.

A preliminary study suggested a lower atherosclerotic burden in CHD patients compared to the general population. In these studies, the incidence of atherosclerosis in a sample of patients aged 11 to 44 years was evaluated based on CIMT measurements, coronary angiography, endothelial function, and lipid profiles as well as15,20-23.

However, the present paper is the first to comprehensively investigate some signs of atherosclerosis in children under 18 years old with CHD. Based on the results of the coronary angiograms, some studies have shown that there is no evidence of coronary artery disease; however, in patients with CHD, the coronary arteries are twisted and narrowed, which makes it difficult to detect plaque on the coronary angiograms20,22,23. In addition, the burden of atherosclerosis can not be quantified by visually evaluating a coronary angiogram.

CIMT is a non-invasive assay to detect subclinical atherosclerosis. It may significantly help in diagnosing the status of patients with atypical chest pain or patients with several cardiovascular risk factors24-26. An increase in the mean of CIMT was observed in patients compared to the healthy group, which was not statistically significant. CIMT was assessed in Çiftel et al.’s investigation similar to our study, they showed CIMT was non-significantly increased in eighteen children with irreversible pulmonary hypertension due to congenital heart disease, while Meyer et al. demonstrated that CIMT in the right common carotid, left common carotid, right common carotid bifurcation, and common carotid bifurcation in patients with a history of coarctation of the aorta and repair, who were between 6 and 17 years old, compared to the control group with 6 to 11 years of age were respectively: 0.48, 0.44, 0.52, and 0.48 compared to 0.38, 0.38, 0.39, and 0.39 mm in all 4 parts. This difference was highly significant27. Sabri et al. reported a considerable augmentation in CIMT in patients with premature coronary arterial disease28. Moreover, Reiner et al. found that even after controlling for confounding factors such as age, sex, height, and weight, children with a history of congenital heart disease still had higher CIMT than controls29.

The results of the current experiment showed that when comparing CIMT among three groups of study subjects, including Tetralogy of Fallot, Pulmonary atresia, and control, the numerical average of CIMT in Tetralogy of Fallot and Pulmonary atresia was considerably higher than in the control group. This is consistent with observations from de Groot et al. and Nielsen et al., who found that children with repaired Tetralogy of Fallot and patients with Pulmonary arterial hypertension had a higher average CIMT, which causes changes in peripheral vascular30-32. However, another study by Tarp et al. suggested that people who underwent surgery in childhood due to congenital CHD are protected from atherosclerosis in adulthood, and their CIMT is low22,33.

In the CCHD group, there were more increases in systolic blood pressure and BMI than in the healthy group. Similar to our research, Eikendal and Gianini et al. reported that disturbances in anthropometry, systolic blood pressure, and increased cholesterol in adolescents and pre-puberty children could be associated with increased CIMT34,35. Moreover, Kamel et al. demonstrated that there is a positive correlation between elevating CIMT and BMI in children with idiopathic nephrotic syndrome36. Moreover, in another experiment, pressure HDL reduction and systolic blood pressure dysregulation were related to the CIMT in 8-year-old children and subjects with cyanotic congenital heart disease37,38.

According to the studies mentioned above and the results obtained in the present study, there may be a correlation between the increase of CIMT and dysregulation of systolic blood pressure in children with CCHD. This relationship leads to the risk of atherosclerosis, which requires more experimentation.

Conclusions

To sum up, Brachial artery FMD and CIMT non-significantly declined and increased in CCHD children, respectively. Increased CIMT and systolic blood pressure may be a risk of developing atherosclerosis in CCHD patients. Further prospective studies with clinical outcomes are needed to assess the nature and significance of endothelial dysfunction in children with CCHD.

Acknowledgements

The authors would like to express their gratitude to all the research participants for their cooperation, as well as to the Pediatric Cardiovascular Research Center for their collaboration.

Conflict of Interest

The authors declare no other competing interests.

Funding

This project was funded by Isfahan University of Medical Sciences.

Author’s Contributions

Conceptualization: N Navabfar, M Ghaderian. Methodology: A Ahmadi. Project administration: N Navabfar, M Ghaderian. Data curation and format analysis: N Navabfar, M R Sabri, Ch Mahdavi. Writing original draft: N Navabfar. Writing-review and editing: B Dehghan, M Ghaderian. Approval of final manuscript: All authors. Software: B Dehghan

References

  • 1.Haas NA, Schirmer KR. Guidelines for the management of congenital heart diseases in childhood and adolescence. Cardiol Young. 2017;27(S3):S1–S105. doi: 10.1017/S1047951116001955. [DOI] [PubMed] [Google Scholar]
  • 2.Varma A, Sharma V, Damke S, Meshram R, Kher A, Vagha J. Clinical Presentation of cyanotic congenital heart diseases in the pediatric population. J Datta Meghe Inst Med Sci Univ. 2020;15(1):7–11. [Google Scholar]
  • 3.Wu W, He J, Shao X. Incidence and mortality trend of congenital heart disease at the global, regional, and national level, 1990-2017. Medicine (Baltimore) 2020 Jun 5;99(23):e20593. doi: 10.1097/MD.0000000000020593. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4.Sun R, Liu M, Lu L, Zheng Y, Zhang P. Congenital Heart Disease: Causes, Diagnosis, Symptoms, and Treatments. Cell Biochem Biophys. 2015 Jul;72(3):857–60. doi: 10.1007/s12013-015-0551-6. [DOI] [PubMed] [Google Scholar]
  • 5.Cristina-Oliveira M, Meireles K, Gil S, Cavalcante Assis F, Geber-Júnior JC, Shinjo SK, et al. Carotid intima-media thickness and flow-mediated dilation do not predict acute in-hospital outcomes in patients hospitalized with COVID-19. Am J Physiol Heart Circ Physiol. 2022 Jun 1;322(6):H906–H13. doi: 10.1152/ajpheart.00026.2022. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6.Rahul I, Krishnamurthy S, Satheesh S, Biswal N, Bobby Z, Lakshminarayanan S. Brachial artery flow-mediated dilatation and carotid intima medial thickness in pediatric nephrotic syndrome: a cross-sectional case-control study. Clin Exp Nephrol. 2015 ;19(1):125–32. doi: 10.1007/s10157-014-0958-1. [DOI] [PubMed] [Google Scholar]
  • 7.Broxterman RM, Witman MA, Trinity JD, Groot HJ, Rossman MJ, Park S-Y, et al. Strong Relationship Between Vascular Function in the Coronary and Brachial Arteries. Hypertension. 2019 ;74(1):208–15. doi: 10.1161/HYPERTENSIONAHA.119.12881. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8.Vlahos AP, Naka KK, Bechlioulis A, Theoharis P, Vakalis K, Moutzouri E, et al. Endothelial dysfunction, but not structural atherosclerosis, is evident early in children with heterozygous familial hypercholesterolemia. Pediatr Cardiol. 2014 ;35(1):63–70. doi: 10.1007/s00246-013-0742-0. [DOI] [PubMed] [Google Scholar]
  • 9.Katz DL, Davidhi A, Ma Y, Kavak Y, Bifulco L, Njike VY. Effects of walnuts on endothelial function in overweight adults with visceral obesity: a randomized, controlled, crossover trial. J Am Coll Nutr. 2012 ;31(6):415–23. doi: 10.1080/07315724.2012.10720468. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10.Xu S, Ilyas I, Little PJ, Li H, Kamato D, Zheng X, et al. Endothelial Dysfunction in Atherosclerotic Cardiovascular Diseases and Beyond: From Mechanism to Pharmacotherapies. Pharmacol Rev. 2021 ;73(3):924–67. doi: 10.1124/pharmrev.120.000096. [DOI] [PubMed] [Google Scholar]
  • 11.Dehghan B, Sabri MR, Hosseinzadeh M, Ahmadi A, Ghaderian M, Sarrafzadegan N, et al. The commencement of congenital heart diseases registry in Isfahan, Iran: Methodology and design. ARYA Atheroscler. 2020 ;16(5):244–7. doi: 10.22122/arya.v16i5.1913. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12.Sorensen KE, Celermajer DS, Spiegelhalter DJ, Georgakopoulos D, Robinson J, Thomas O, et al. Non-invasive measurement of human endothelium dependent arterial responses: accuracy and reproducibility. Br Heart J. 1995 ;74(3):247–53. doi: 10.1136/hrt.74.3.247. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13.Manganaro A, Ciracì L, Andrè L, Trio O, Manganaro R, Saporito F, et al. Endothelial dysfunction in patients with coronary artery disease: insights from a flow-mediated dilation study. Clin Appl Thromb Hemost. 2014 ;20(6):583–8. doi: 10.1177/1076029614524620. [DOI] [PubMed] [Google Scholar]
  • 14.Oechslin E, Kiowski W, Schindler R, Bernheim A, Julius B, Brunner-La Rocca HP. Systemic endothelial dysfunction in adults with cyanotic congenital heart disease. Circulation. 2005 ;112(8):1106–12. doi: 10.1161/CIRCULATIONAHA.105.534073. [DOI] [PubMed] [Google Scholar]
  • 15.Çiftel M, Şimşek A, Turan Ö, Kardelen F, Akçurin G, Ertuğ H. Endothelial dysfunction and atherosclerosis in children with irreversible pulmonary hypertension due to congenital heart disease. Ann Pediatr Cardiol. 2012 ;5(2):160–4. doi: 10.4103/0974-2069.99619. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16.Cordina RL, Nakhla S, O’Meagher S, Leaney J, Graham S, Celermajer DS. Widespread endotheliopathy in adults with cyanotic congenital heart disease. Cardiol Young. 2015 ;25(3):511–9. doi: 10.1017/S1047951114000262. [DOI] [PubMed] [Google Scholar]
  • 17.Tarp JB, Clausen P, Celermajer D, Christoffersen C, Jensen AS, Sørensen K, et al. Vascular function in adults with cyanotic congenital heart disease. Int J Cardiol Heart Vasc. 2020 Sep;30:100632. doi: 10.1016/j.ijcha.2020.100632. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18.Pedersen CM, Schmidt MR, Mortensen B, Contractor H, Bøtker HE, Kharbanda RK, et al. Preserved flow-mediated dilation in adults with cyanotic congenital heart disease. Pediatr Cardiol. 2009 ;30(7):965–70. doi: 10.1007/s00246-009-9489-z. [DOI] [PubMed] [Google Scholar]
  • 19.Sabri MR, Dehghan B, Yaghini O, Nasiri J, Mansourian M, Khalifehsoltani S. Endothelial dysfunction state in migraine headache and neutrally mediated syncope in children and young adults. J Res Med Sci. 2015 ;20(8):771–6. doi: 10.4103/1735-1995.168384. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 20.Giannakoulas G, Dimopoulos K, Engel R, Goktekin O, Kucukdurmaz Z, Vatankulu MA, et al. Burden of coronary artery disease in adults with congenital heart disease and its relation to congenital and traditional heart risk factors. Am J Cardiol. 2009 ;103(10):1445–50. doi: 10.1016/j.amjcard.2009.01.353. [DOI] [PubMed] [Google Scholar]
  • 21.Mayyas F, Niebauer M, Zurick A, Barnard J, Gillinov AM, Chung MK, et al. Association of left atrial endothelin-1 with atrial rhythm, size, and fibrosis in patients with structural heart disease. Circ Arrhythm Electrophysiol. 2010 ;3(4):369–79. doi: 10.1161/CIRCEP.109.924985. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 22.Tarp JB, Jensen AS, Engstrøm T, Holstein-Rathlou N-H, Søndergaard L. Cyanotic congenital heart disease and atherosclerosis. Heart. 2017 ;103(12):897–900. doi: 10.1136/heartjnl-2016-311012. [DOI] [PubMed] [Google Scholar]
  • 23.Fyfe A, Perloff JK, Niwa K, Child JS, Miner PD. Cyanotic congenital heart disease and coronary artery atherogenesis. Am J Cardiol. 2005 ;96(2):283–90. doi: 10.1016/j.amjcard.2005.03.060. [DOI] [PubMed] [Google Scholar]
  • 24.Sillesen H, Sartori S, Sandholt B, Baber U, Mehran R, Fuster V. Carotid plaque thickness and carotid plaque burden predict future cardiovascular events in asymptomatic adult Americans. Eur Heart J Cardiovasc Imaging. 2018 ;19(9):1042–50. doi: 10.1093/ehjci/jex239. [DOI] [PubMed] [Google Scholar]
  • 25.Mahdavi-Roshan M, Salari A, Doostdar-Sanaye M. Brachial endothelial function and carotid intima-media thickness in patients with coronary artery disease. Arch Adv Biosci. 2015;6(4):15–9. [Google Scholar]
  • 26.Bytyçi I, Shenouda R, Wester P, Henein MY. Carotid Atherosclerosis in Predicting Coronary Artery Disease: A Systematic Review and Meta-Analysis. Arterioscler Thromb Vasc Biol. 2021 ;41(4):e224–e37. doi: 10.1161/ATVBAHA.120.315747. [DOI] [PubMed] [Google Scholar]
  • 27.Meyer A, Joharchi M, Kundt G, Schuff-Werner P, Steinhoff G, Kienast W. Predicting the risk of early atherosclerotic disease development in children after repair of aortic coarctation. Eur Heart J. 2005 ;26(6):617–22. doi: 10.1093/eurheartj/ehi037. [DOI] [PubMed] [Google Scholar]
  • 28.Sabri MR, Kelishadi R. The thickness of the intimal and medial layers of the carotid arteries, and the index of left ventricular mass, in children of patients with premature coronary arterial disease. Cardiol Young. 2007 ;17(6):609–16. doi: 10.1017/S1047951107001357. [DOI] [PubMed] [Google Scholar]
  • 29.Reiner B, Oberhoffer R, Häcker AL, Ewert P, Müller J. Carotid Intima-Media Thickness in Children and Adolescents With Congenital Heart Disease. Can J Cardiol. 2018 ;34(12):1618–23. doi: 10.1016/j.cjca.2018.09.012. [DOI] [PubMed] [Google Scholar]
  • 30.de Groot PC, Thijssen D, Binkhorst M, Green DJ, Schokking M, Hopman MT. Vascular function in children with repaired tetralogy of Fallot. Am J Cardiol. 2010 ;106(6):851–5. doi: 10.1016/j.amjcard.2010.05.009. [DOI] [PubMed] [Google Scholar]
  • 31.Goeder D, Oberhoffer-Fritz R, Brudy L, Willinger L, Meyer M, Ewert P, et al. Diminished Endothelial Function but Normal Vascular Structure in Adults with Tetralogy of Fallot. J Clin Med. 2022 ;11(3):493. doi: 10.3390/jcm11030493. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 32.Naessen T, Einarsson G, Henrohn D, Wikström G. Peripheral Vascular Ageing in Pulmonary Arterial Hypertension as Assessed by Common Carotid Artery Intima Thickness and Intima/Media Thickness Ratio: An Investigation Using Non-Invasive High-Resolution Ultrasound. Heart Lung Circ. 2023 ;32(3):338–47. doi: 10.1016/j.hlc.2022.10.017. [DOI] [PubMed] [Google Scholar]
  • 33.Tarp JB, Sørgaard MH, Christoffersen C, Jensen AS, Sillesen H, Celermajer D, et al. Subclinical atherosclerosis in patients with cyanotic congenital heart disease. Int J Cardiol. 2019 Feb;277:97–103. doi: 10.1016/j.ijcard.2018.08.104. [DOI] [PubMed] [Google Scholar]
  • 34.Giannini C, Diesse L, D’adamo E, Chiavaroli V, De Giorgis T, Di Iorio C, et al. Influence of the Mediterranean diet on carotid intima-media thickness in hypercholesterolaemic children: a 12-month intervention study. Nutr Metab Cardiovasc Dis. 2014 ;24(1):75–82. doi: 10.1016/j.numecd.2013.04.005. [DOI] [PubMed] [Google Scholar]
  • 35.Eikendal AL, Groenewegen KA, Bots ML, Peters SA, Uiterwaal CS, den Ruijter HM. Relation Between Adolescent Cardiovascular Risk Factors and Carotid Intima-Media Echogenicity in Healthy Young Adults: The Atherosclerosis Risk in Young Adults (ARYA) Study. J Am Heart Assoc. 2016 ;5(5):e002941. doi: 10.1161/JAHA.115.002941. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 36.Kamel AS, AlGhawass MME, Sayed MA, Roby SA. Evaluation of carotid intima media thickness in children with idiopathic nephrotic syndrome. Ital J Pediatr. 2022 ;48(1):195 . doi: 10.1186/s13052-022-01383-7. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 37.Ayer JG, Harmer JA, Nakhla S, Xuan W, Ng MK, Raitakari OT, et al. HDL-cholesterol, blood pressure, and asymmetric dimethylarginine are significantly associated with arterial wall thickness in children. Arterioscler Thromb Vasc Biol. 2009 ;29(6):943–9. doi: 10.1161/ATVBAHA.109.184184. [DOI] [PubMed] [Google Scholar]
  • 38.Sabri MR, Daryoushi H, Gharipour M. Endothelial function state following repair of cyanotic congenital heart diseases. Cardiol Young. 2015 ;25(2):222–7. doi: 10.1017/S104795111300187X. [DOI] [PubMed] [Google Scholar]

Articles from ARYA Atherosclerosis are provided here courtesy of Isfahan Cardiovascular Research Institute, Isfahan University of Medical Sciences

RESOURCES